Home » Author Archive

Image for Direxion Daily TSLA Bull 2X Shares (NASDAQ:TSLL) Shares Gap Up   – Time to Buy?

Direxion Daily TSLA Bull 2X Shares (NASDAQ:TSLL) Shares Gap Up – Time to Buy?

Direxion Daily TSLA Bull 2X Shares (NASDAQ:TSLL – Get Free Report) shares gapped up before the market opened on Tuesday . The stock had previously closed at $29.50, but opened at $30.39. Direxion Daily TSLA Bull 2X Shares shares... More of this article »
Image for Molina Healthcare, Inc. (NYSE:MOH) Receives Consensus Recommendation of “Hold” from Analysts

Molina Healthcare, Inc. (NYSE:MOH) Receives Consensus Recommendation of “Hold” from Analysts

Molina Healthcare, Inc. (NYSE:MOH – Get Free Report) has been given an average rating of “Hold” by the twelve research firms that are presently covering the stock, Marketbeat reports. One equities research analyst... More of this article »
Image for The Goldman Sachs Group (NYSE:GS) Stock Unloaded Sen. Markwayne Mullin

The Goldman Sachs Group (NYSE:GS) Stock Unloaded Sen. Markwayne Mullin

Senator Markwayne Mullin (R-Oklahoma) recently sold shares of The Goldman Sachs Group, Inc. (NYSE:GS). In a filing disclosed on December 31st, the Senator disclosed that they had sold between $15,001 and $50,000 in The Goldman Sachs... More of this article »
Image for Camping World Holdings, Inc. (NYSE:CWH) Receives $28.00 Average Price Target from Brokerages

Camping World Holdings, Inc. (NYSE:CWH) Receives $28.00 Average Price Target from Brokerages

Camping World Holdings, Inc. (NYSE:CWH – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the nine research firms that are currently covering the company, Marketbeat.com reports. One analyst... More of this article »
Image for TRACON Pharmaceuticals (NASDAQ:TCON) Now Covered by StockNews.com

TRACON Pharmaceuticals (NASDAQ:TCON) Now Covered by StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Get Free Report) in a research report issued on Tuesday. The brokerage set a “hold” rating on the biopharmaceutical... More of this article »